| 2018年 12月31日 | 2019年 12月31日 | 2020年 12月31日 | 2021年 12月31日 | 2022年 12月31日 |
---|
Cash | - | 34,382 | 31,327 | 19,437 | 362,609 |
---|
Restricted cash | 14,674 | 15,915 | - | 5,627 | 4,984 |
---|
Accounts receivable, net | 200,776 | 86,494 | 199,367 | 46,613 | 110,687 |
---|
Other current assets | 65,011 | 194,173 | 90,109 | 252,790 | 230,319 |
---|
Inventory, net | 53,344 | 102,782 | 85,243 | 68,421 | 38,730 |
---|
Total current assets | 478,753 | 433,746 | 406,046 | 392,888 | 747,329 |
---|
Property and equipment, net | 300,702 | 248,316 | 144,865 | 91,658 | 125,548 |
---|
Intangible asset, net | 4 | 3 | 3 | 3 | - |
---|
Goodwill | 3 | 3 | 3 | 3 | 3 |
---|
Right of use asset | - | - | - | - | 135,107 |
---|
Total non-current assets | 7 | 7 | 6 | 6 | 3 |
---|
Total assets | 8 | 7 | 7 | 6 | 4 |
---|
Short term bank credit | - | 92,230 | 55,845 | 69,877 | - |
---|
Short term loans | - | 14,489 | - | 234,004 | - |
---|
Trade payables | 709,269 | 783,592 | 612,129 | 626,271 | 508,716 |
---|
Employees and payroll accruals | 359,273 | 680,290 | 750,872 | 1 | 694,709 |
---|
Accrued expenses and other current liabilities | 842,142 | 790,097 | 2 | 3 | 3 |
---|
Convertible loans | 226,661 | 4 | 7 | 2 | 1 |
---|
Warrants presented at fair value | - | -158,112 | -7,343,894 | -17,296 | - |
---|
Current maturity of lease liability | - | - | - | - | 60,071 |
---|
Total current liabilities | 2 | 6 | 17 | 7 | 5 |
---|
Capital note | - | - | 40,000 | 40,000 | 40,000 |
---|
Warrants presented at fair value | 945,025 | 1 | 1 | 89,679 | 15,459 |
---|
Israel Innovation Authority | - | - | -755,980 | -381,216 | - |
---|
Lease liability, net of current maturity | - | - | - | - | 75,036 |
---|
Total non-current liabilities | 3 | 2 | 2 | 510,895 | 130,495 |
---|
Total liabilities | 5 | 8 | 19 | 7 | 5 |
---|
Ordinary shares of NIS 0.01 par value - Authorized: 1,200,000,000 as of December 31, 2022 and 2021, respectively; Issued and outstanding: 147,134,792 and 90,205,191 ordinary shares as of December 31, 2022 and 2021, respectively | 63,301 | 65,842 | 73,403 | 270,750 | 441,590 |
---|
Additional paid in capital | 20 | 20 | 21 | 35 | 39 |
---|
Treasury stocks | - | - | 122,482 | 122,482 | 122,482 |
---|
Accumulated deficit | -17,058,758 | -21,011,763 | -33,555,500 | -36,074,364 | -40,583,911 |
---|
Total shareholders’ deficit | - | -994,289 | -12,871,745 | -1,015,863 | -1,407,895 |
---|
Total liabilities and shareholders’ deficit | 8 | 7 | 7 | 6 | 4 |
---|